Stryker Corporation (SYK)
| Market Cap | 113.78B |
| Revenue (ttm) | 19.89B |
| Net Income (ttm) | 2.59B |
| Shares Out | 379.94M |
| EPS (ttm) | 6.74 |
| PE Ratio | 44.43 |
| Forward PE | 25.97 |
| Dividend | $3.20 (1.07%) |
| Ex-Dividend Date | Dec 28, 2023 |
| Volume | 875,964 |
| Open | 299.61 |
| Previous Close | 299.12 |
| Day's Range | 298.06 - 300.35 |
| 52-Week Range | 241.68 - 306.93 |
| Beta | 0.95 |
| Analysts | Buy |
| Price Target | 319.33 (+6.64%) |
| Earnings Date | Jan 30, 2024 |
About SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgi... [Read more]
Financial Performance
In 2022, Stryker's revenue was $18.45 billion, an increase of 7.84% compared to the previous year's $17.11 billion. Earnings were $2.36 billion, an increase of 18.25%.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $319.33, which is an increase of 6.64% from the latest price.
News
Stryker announces intent to acquire SERF SAS, enhancing its global joint replacement leadership
MAHWAH, N.J., USA , Dec. 18, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, announced today that it has executed a binding offer to Menix to acquire...
Stryker announces Dr. Srikant Datar will retire from Board of Directors
Kalamazoo, Michigan, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 15 years of distinguished service, Dr. Srikant Datar has notified the Company that he will not stan...
Stryker declares a $0.80 per share quarterly dividend
Kalamazoo, Michigan, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable January 31, 2024 to shareho...
Bulgarian parliament okays $1.5 billion purchase of Stryker fighting vehicles from US
The Bulgarian parliament on Thursday approved a $1.5 billion purchase of Stryker fighting vehicles from the United States to modernise the country's army and bring it in line with NATO standards, the ...
Stryker tightens profit forecast on steady demand for its medical devices
Stryker Corp on Thursday raised the lower end of its full-year profit forecast as the medtech company sees steady demand for its medical and surgical devices from a post-pandemic pick-up in volumes of...
Stryker reports third quarter 2023 operating results
Kalamazoo, Michigan, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter Results Reported net sales increased 9.6% to $4.9 bill...
Stryker to participate in the 6th Annual Evercore ISI HealthCONx Conference
Kalamazoo, Michigan, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023 at the Kimpton EPIC Hote...
The Value Deepens for Medtech Stocks: Reversal Imminent
Results from Johnson & Johnson NYSE: JNJ and Abbott Laboratories NYSE: ABT foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength...
Over 2,400 Surgical Cases Completed Using Stryker's Q Guidance System with Spine Guidance Software in First Year
LEESBURG, Va.--(BUSINESS WIRE)--The Q Guidance System with Spine Guidance Software has been used to deliver enhanced surgical planning and navigation in over 2,400 spinal cases.
What other industries could weight loss drugs disrupt?
Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
Stryker to host investor day
Kalamazoo, Michigan, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Investor Day on Wednesday, November 8, 2023, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey.
Both Wall Street and food companies are overreacting to weight-loss drugs, say Herb Greenberg
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy.
Stryker to announce financial results for its third quarter of fiscal year 2023
Kalamazoo, Michigan, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for third quarter of fiscal year 2023 on Thursday, November 2, 2023. A press ...
Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact
Over 1 million Triathlon Cementless Knees implanted globally MAHWAH, N.J. , Sept. 21, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, continues its y...
Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions
KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker launched its PROstep® MIS Lapidus, a new minimally invasive surgical option for treating patients with bunions.
A Clearer Vision of Surgery: Stryker Releases its Next-Generation of Advanced Surgical Cameras
Stryker's 1788 camera platform brings enhanced technology to the operating room – including a wider color gamut, more vivid white light and new fluorescence imaging capabilities SAN JOSE, California, ...
Stryker's Pangea Systems Receive FDA Clearance
KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker's Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility have received 510k clearance from the U.S. Food & Drug Administration.
A Significant Reversal is in Sight for These 5 Med Tech Companies
Med tech has been on the skids for no fault of its own. It's not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has normaliz...
Final Trades: NextEra Energy, Stryker & Zimmer Holdings
The "Halftime Report" traders give their top picks to watch for the second half.
Stryker to participate in the 2023 Wells Fargo Securities Healthcare Conference
Kalamazoo, Michigan, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2023 Wells Fargo Securities Healthcare Conference on Thursday, September 7, 2023.
Is Stryker Corp (SYK) Fairly Valued? An In-depth Analysis
Today, Stryker Corp ( SYK , Financial) experienced a daily change of 3.27%, with an Earnings Per Share (EPS) of 6.87. The question on the minds of many investors is whether the stock is fairly valued.
Final Trades: Boeing, Stryker & Wynn
The "Halftime Report" traders give their top picks to watch for the second half.
Stryker CEO: We're in the midst of 'supercycle of innovation' across our capital equipment business
Kevin Lobo, Stryker CEO, joins 'Squawk on the Street' to discuss the key factors for Stryker's growth, how long the backlog of procedures will last for the company, and Stryker's next catalyst for gro...
Stryker launches national direct-to-patient marketing campaign
"Scan. Plan. Mako Can." spotlights and differentiates Stryker's Mako SmartRobotics™ for partial knee, total knee and total hip replacement surgery MAHWAH, N.J.